Characterization of the Temporo-masseteric Nerve Block (TMNB) in Healthy Subjects
ConditionOcclusion
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-64
SponsorRutgers, The State University of New Jersey
About this trial
The proposed pilot study is aimed at preliminary characterization of the TMNB injection in 20 healthy volunteers. Assessment of bite-force distribution and surface electromyographic activity of the temporalis and the masseter muscles, at rest and clench, before and after unilateral TMNB injection, will be the primary outcome measures. Post-injection assessments will be performed at 30 minutes, 2 hours, and 2 weeks after the injection. Participants will be surveyed regarding their experience receiving the TMNB injection (secondary outcomes).
Eligibility criteria
Qualifiers
18-64 years of age
All ethnicity
Male and female sex
Fluent in written/spoken English
Disqualifiers
Traumatic injury/ surgery on face or jaw < 6 months
current orthodontic treatment
pregnant or nursing,
kidney failure or renal dialysis,
Trial design
Treatments tested in this trial
- Temporomasseteric Nerve Block
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov